Rilutek

Active Ingredient(s): Riluzole
FDA Approved: * December 12, 1995
Pharm Company: * SANOFI AVENTIS US
Category: Neurological Disorders

Riluzole is a medication used to treat amyotrophic lateral sclerosis and other motor neurone diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months.[2] Riluzole is available in tablet and liquid form. Contents 1 Medical use 1.1 Amyotrophic lateral sclerosis 2 Adverse effects 2.1 Overdose 3 Contraindications 3.1 Interactions 4 Mechanism of action 5 Synthesis 6 Society and culture 6... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Rilutek RPR;202
Rilutek 50 mg Oral Tablet
NDC: 0075-7700
Labeler:
Sanofi-aventis U.S. LLC
Rilutek RPR;202
Rilutek 50 mg Oral Tablet
NDC: 24987-700
Labeler:
Covis Pharmaceuticals, Inc.
Rilutek RPR;202
Rilutek 50 mg/1 Oral Tablet
NDC: 0179-0143
Labeler:
Kaiser Foundation Hospitals
Rilutek RPR;202
Rilutek 50 mg Oral Tablet
NDC: 70515-700
Labeler:
Covis Pharma

Related Brands

Drugs with the same active ingredients